The March of Dimes reports that one in 20 U.S. counties had less available maternity care in 2022 compared to 2020. About 2.2 million women (who had 150,000 babies last year) live in counties with no maternity care at all – no hospitals, no obstetricians and no midwives.
These “maternity deserts” are primarily rural, and women often must travel over an hour to reach a provider. Telemedicine helped some get prenatal care remotely, but state regulations limiting telemedicine to in-state providers that were lifted early in the pandemic are now returning.
The lack of local maternity care contributes to the U.S. maternal mortality rate, which is higher than any other developed country.
Implications for employers:
The New England Journal of Medicine reported on a randomized study of colonoscopy invitations given to almost 30,000 people ages 55 to 65 in Norway, Sweden and Poland. Those who were randomly assigned to this invitation were compared to about twice as many people who were not given this invitation. Of those who got the invitation, 42% actually got colonoscopies. The report does not say how many in the “usual care” group received a colonoscopy.
Those who got a colonoscopy invitation had statistically significantly fewer colon cancers than the control group. They had fewer colorectal cancer deaths too, although this did not reach statistical significance. All-cause mortality was not different between the two groups. The colonoscopies were performed from 2009 to 2014, so a mortality benefit could still reach statistical significance with more time. Researchers reported that it took 455 invitations to prevent one case of colorectal cancer.
Colonoscopy screening is more common in the U.S. than in these European countries. Other research has shown a substantial decrease in colorectal cancer deaths in the U.S. associated with an increase in colonoscopy.
Implications for employers:
Researchers in the U.K. studied 78,500 people ages 40 to 79 by giving them an accelerometer for a week to calculate steps taken, and then followed participants for a median of seven years to see if they died of cancer or heart disease. There were statistically significantly fewer deaths from cancer and heart disease or any other cause in those who had more steps (up to 10,000 steps a day, after which additional steps were not associated with further decrease in risk).
This is a strong study because of its size and robust adjustment for other risks of death such as age or smoking. However, a week of accelerometer monitoring might not have represented usual exertion, and the population was non-diverse. Overall, this adds to evidence that exercise is good for overall health.
Implications for employers:
Jeff is an internal medicine physician and has led WTW’s clinical response to COVID-19 and other health-related topics. He has served in leadership roles in provider organizations and a health plan and is an Assistant Professor at Harvard Chan School of Public Health.